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Abstract (100 words) 
 
The liver is an organ consisting of the largest reticulo-endothelial cell network in 
the body and playing an important role in host defense against invading 
microorganisms. The organ is comprised of parenchymal cells and many different 
types of non-parenchymal cells, all of which play significant role. Even biliary 
epithelial cells are not only the target in autoimmune liver diseases but also have 
central role in orchestrating several immune cells involved in both innate and 
acquired immunity. Tissue damage caused by various agents results in fibrosis, 
inflammation, necrosis, fibrosis and eventually distortion of normal hepatic 
architecture, cirrhosis, and functional deterioration. 
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 The liver has a particularly intriguing immunological milieu consisting of 
a largest reticulo-endothelial cell network in the body and being a major source of 
many components of the innate immune response including acute phase and 
complement proteins as well as inflammatory cytokines and chemokines. The 
organ is also a significant site of immune-mediated damage initiated by infectious, 
autoimmune and malignant stimuli. Recent studies have demonstrated that the 
liver is also an important site of innate immune system. The innate or natural 
immune system is the first rapid line-defense against environmental threats such 
as microbial infection and physical or chemical injury. Sequential activation of 
innate and adaptive immune response is crucial for elimination of 
microorganisms and for immune response orchestrated by dendritic cells linking 
innate and adaptive arms of immune system. Unique repertoires of dendritic and 
lymphoid cells including NKT cells and regulatory T lymphocytes modify the 
immune response in the liver. Non-immune cells of the liver including endothelial 
cells, hepatocytes and biliary epithelial cells also contribute to local 
immunological potential. All of these elements play roles, together and 
independently, determining the outcome of immunological stimulation within the 
liver. In addition, immune response upon exposure to exogenous or autogenic 
agents varies depending on the host genetic backgrounds. The genetic basis of 
immune response will offer new approaches to understanding the pathophysiology, 
diagnosis and management of patients with liver diseases.  
 
Liver architecture  
 The liver is the largest organ comprising about l/50 of the adult body 
weight. Structurally and histologically, the liver can be divided into 5 tissue 
systems: 1) vascular system, 2) hepatocytes and hepatic lobule, 3) hepatic 
sinusoidal cells, 4) biliary system, and 5) stroma. The organ is composed of many 
different cell types which are divided into parenchymal cells (hepatocytes) and 
nonparenchymal cells (Table 1). It has been estimated that the hepatocyte 
population accounts for approximately 78% of the liver tissue volume, while 
non-parenchymal cells constitute about 6.3% in which about 2.8% are endothelial 
cells, 2.1% Kupffer cells, and 1.4% hepatic stellate cells. The extracellular space 
represents approximately 16% of the liver tissue volume [10].  
 
Vascular system 




The liver receives portal blood enriched with nutrients absorbed by 
intestine from splanchnic circulation via portal vein. The portal blood also 
contains substances secreted by pancreas, intestine and spleen. Hepatocytes take 
up, metabolize, biotransform and store a great variety of incoming substances. 
They also de novo synthesize and secrete substances to other organs in the body. 
The role of the liver is to provide appropriate amounts of solutes needed for 
adequate functioning of distant organs such as brain, heart, and kidneys. The 
interaction between blood and liver cells occurs at the level of the liver cell plate. 
In addition to the blood supply by portal vein, the liver is also perfused by hepatic 
artery which carries blood with a high oxygen content. This completes a perfusion 
circuit encompassing the splanchnic-sinusoidal-systemic circulation. There is 
another circuit to which the liver actively contributes, the entero-hepatic 
circulation.  
 
Hepatocytes and hepatic lobule 
 The hepatic lobule is the structural and functional unit of the liver (Fig. 1) 
[53]. It consists of a roughly hexagonal arrangement of plates of hepatocytes 
which extend forming liver cell plates of 1-cell-thick by15-25 hepatocytes in length. 
Between the two cell-plates, blood flows from the portal tract to the terminal 
hepatic venule, forming so called “sinusoid”. All the hepatocytes, seems to be 
apparently homogeneous by light microscopy. Though, there are some functional 
differences between periportal hepatocytes which locate closer to portal venule 
and centrilobular ones located closer to central hepatic venule [9]. The portal tract 
contains a portal venule, a hepatic arteriole, and bile ducts. Blood flows from the 
portal vein into hepatic sinusoids, perfuses the liver cell plate and flows out into 
the hepatic venule in the central acinus reaching systemic circulation.  
Two structural characteristics are critical for liver functions to be 
accomplished: (a) hepatocytes located in different positions between the portal 
tract and the hepatic venule express different genes and attain distinct functional 
capabilities, and (b) given this functional compartmentation, the sequential 
perfusion of hepatocytes in the liver cell plate, from portal to hepatic venule, 
allows progressive qualitative modification of the sinusoidal blood composition as 
it traverses the liver. 
 
Hepatic sinusoidal cells 
 Nonparenchymal cells encompass endothelial cells, Kupffer cells, hepatic 
stellate cells (or Ito or fat-storing cells), and Pit cells, all of which are located in 
sinusoids and called as “hepatic sinusoidal cells” [69]. Endothelial cells form the 




walls of the hepatic sinusoids (Fig. 2). The extended processes of the endothelial 
cells have pores or fenestrations through which solutes can apparently move 
freely into the perisinusoidal space of Disse. Alcoholics or cirrhotics who have 
developed liver fibrosis show disturbances in solutes exchange between blood and 
hepatocytes due to loss of the endothelial cell fenestrations concomitantly with the 
appearance of endothelial cell basal membranes. Kupffer cells are intravascular 
tissue macrophages which remove relatively large particles from the circulation, 
while endothelial cells take up rather small particles. Hepatic stellate cells (or Ito 
or fat-storing cells) are responsible for the storage of vitamin A and play a major 
role in the development of hepatic fibrosis in response to injury [17]. Pit cells 
which account for a small proportion of the non-hepatocyte liver cells are natural 
killer cells located beneath endothelial cells and fibroblasts.  
 
Biliary system and biliary epithelial cells 
Hepatocytes secrete bile into the bile canaliculi. Their flow is parallel to 
the sinusoids, but is in opposite direction to the blood flows (Fig. 3). Via biliary 
secretion, the liver excretes substances in feces and participates in intestinal 
functions such as intestinal absorption of fats by supplying bile acids. At the ends 
of the bile canaliculi, bile flows into bile ducts, which are true ducts lined with 
epithelial cells. Biliary cells form conduits (biliary system) carrying bile into the 
gall bladder and small intestine with bile flowing from hepatocytes near the 
hepatic venule to portal tract bile ducts. Bile duct cells also contribute to bile 
formation (ductular component of bile formation). Biliary epithelial cells 
represent about 3.5％ of the liver nuclear population. 
 
Distortion of normal hepatic architecture: Cirrhosis 
Cirrhosis is a consequence of chronic liver disease characterized by 
replacement of liver tissue by dense fibrous scar tissue as well as regenerative 
nodules formation which result in widespread distortion of normal hepatic 
architecture. It is most commonly caused by hepatitis B and C, alcohol-induced 
liver injury, autoimmune liver diseases and fatty liver disease but may have many 
other possible causes and be cryptogenic in some cases. 
Loss of liver tissue due to injury results in fibrosis, regeneration and 
hyperplasia of liver cells and arterial growth (angiogenesis) induced by growth 
regulators which include cytokines and hepatic growth factors; e.g., hepatocyte 
growth factor, epithelial growth factor, transforming growth factor-α, tumor 
necrosis factor. Hormones, including insulin, glucagon, and change of intrahepatic 




blood flow patterns determine localization and peculiarities of nodules formation. 
Portal hypertension is the most common complication of cirrhosis. 
Angiogenesis produces new vessels within the fibrous sheath that surrounds 
nodules. These new vessels connect hepatic artery and portal vein to hepatic 
venules, thereby restoring intrahepatic circulatory pathways. Such 
interconnecting vessels provide relatively low-volume, high-pressure venous 
drainage and as a result portal vein pressure increase. Such distortions in blood 
flow contribute to portal hypertension. 
Progressive loss of hepatic architecture impairs hepatic function, leading 
to hepatic insufficiency which manifest as coagulopathy, renal failure, and hepatic 
encephalopathy. Hepatocellular carcinoma frequently complicates cirrhosis, 
particularly cirrhosis resulting from chronic hepatitis B and C. 
 
 
Liver cells in innate immune response 
The liver has a number of important functions in systemic and local host 
defense including both innate and adaptive immunity, and inflammatory reaction. 
The organ is perfused with antigen-rich blood from the gastrointestinal tract, 
cytokine-rich blood from the spleen and oxygen and metabolite-rich blood from the 
systemic artery through a network of sinusoids. The parenchymal cells 
(hepatocytes) secrete acute phase proteins such as C-reactive protein, 
anti-1-antitrypsin, ceruloplasmin or haptoglobin in response to IL-6 secreted 
from Kupffer cells, thus controlling systemic and local inflammatory reactions. 
Each of non-parenchymal cells plays important role in normal physiology and 
homeostasis, and also participates in systemic as well as in local inflammation 
and immune response [39]. 
Innate immunity can detect infection through pattern-recognition 
receptors (PRRs) such as Toll-like receptors (TLRs) that recognizing specific 
structures, called pathogen-associated molecular patterns (PAMPs) that are 
expressed by invading pathogens [21].There are many different cell types in the 
liver which express a variety of TLRs: parenchymal cells and non-parenchymal 
cells which include biliary epithelial cells, sinusoidal endothelial cells, Kupffer 
cells, hepatic stellate cells, hepatic dendritic cells, NK cells, and NKT cells [56,57]. 
TLRs are the key components of the innate immune system, which activate 
multiple inflammatory pathways and coordinate systemic defense against 
pathogens. In addition to TLRs, cytoplasmic pattern recognition receptors, such 
as nucleotide-binding oligomerization domain (NOD)-like receptors and the RNA 




helicase family can detect microbial components that enter the cell’s cytoplasm 
and induce innate immunity [34]. The best defined PAMPs include LPS found on 
gram-negative bacteria and peptidoglycan found on gram-positive bacteria. 
 
Kupffer cells  
Kupffer cells reside within the lumen of the liver sinusoids, therefore, they 
are the first cells to be exposed to materials absorbed from the gastrointestinal 
tract [46]. These cells are resident macrophages of the liver and constitute 80～
90% of the tissue macrophages presenting in the body. Kupffer cells are the 
principal liver cells for phagocytosis, antigen presentation and production of 
proinflammatory cytokines. Activation of Kupffer cells by pathogenic agents 
results in release of inflammatory mediators, growth factors, and reactive oxygen 
species (ROS) [8]. This activation appears to be required for the normal 
physiological functioning of the liver, such as removal of or tolerance to pathogens, 
as well as occurs in acute hepatic injury [66]. Understanding the role of Kupffer 
cells in these diverse responses is a key to understanding mechanisms of liver 
physiology and pathology.  
Kupffer cells express a variety TLRs, which participate in liver injury. The 
TLR4 protein has been detected on Kupffer cells and is likely involved in uptake 
and clearance of endotoxins, production of cytokines and ROS. Expression of 
functional TLR2 has also been reported in Kupffer cells and activation of TLR2 
leads to production of proinflammatory cytokines [42]. Kupffer cells-derived 
cytokines play a key role in modulation of other cells. In response to LPS, Kupffer 
cells produce TNF-α and IL-10, which downregulate receptor-mediated antigen 
uptake and MHC class II-expression on LSEC and DCs and decrease T cell 
activation [55]. Kupffer cells are involved in the pathogenesis of liver injury 
through the release of biologically active substances. Activated Kupffer cells are 
the major source of inflammatory mediators including cytokines, superoxide, 
nitric oxide, eicosanoids, and chemokines [52], while in the non-inflamed liver, 
Kupffer cells secrete anti-inflammatory mediators, such as IL-10, endogenous 
prostanoids and TGF-β[26]. Activated Kupffer cells exposed to pro-inflammatory 
mediators such as LPS or bacterial products, secrete pro-inflammatory cytokines 
(TNF-α, IFN-α), chemokines (MCP-I, IL-8) and reactive oxygen/nitrogen species 
which contribute to liver injury [61].  Kupffer cells also stimulate profibrogenic 
response by production of TGF-β1, matrix metalloproteinases, platelet-derived 
growth factor, and ROS. Since Kupffer cells are the first cell to encounter 
gut-derived toxins including LPS, they are adapted to less respond to LPS, which 
is called “LPS tolerance” under the physiological environment.  





Hepatic stellate cells (HSCs) and other liver sinusoidal cells 
HSCs are located in the space of Disse and are the principal cellular 
sources for the production of extracellular matrix proteins, such as collagen type I, 
III, and IV in the liver. Upon TLR4 ligation, TLR4 signaling induces upregulation 
of proinflammatory molecules including chemokines (CCL2, CCL3, and CCL4) 
and adhesion molecules (VCAM-1, ICAM-1, and E-selection). TLR4 signaling also 
enhances profibrogenic signaling such as TGF-β signaling [58].  
LSECs express TLR4 and TLR4 signaling induces production of TNF-α 
and ROS.  Innate immune response in LSEC is also modulated by “LPS 
tolerance”. Other cell types involved in innate immunity in the liver are hepatic 
dendritic cells (DC), plasmatoid DC (pDC) and conventional DC (cDC), liver NK 
cells, and NKT cells. Hepatic DC are professional antigen-presenting cells (APC) 
in the liver. pDCs are also the principal cells producing IFN-α in response to the 
ligands for TLR7 and TLR9, while cDC produces TNF-α and IL-6 in response to 
TLR4, TLR7, and TLR9 [56,57].   
Hepatocytes and biliary epithelial cells (BEC) express almost all TLRs at 
mRNA and protein levels. The ligation of TLR4 and 2 on both hepatocytes and 
BEC by LPS and lipopeptides, respectively, induces TLR signaling through NFκ B 
and p38/c-jun N-terminal kinase (JNK) resulting in proinflammatory cytokine 
production such as TNF-α, IL-6, IL-12 [14,56,57,72]. 
 
TLRs and liver diseases  
The interplay between TLRs and their exogenous and/or endogenous TLR 
ligands is involved in pathogenesis of various liver diseases [56,57]. Since the liver 
is constantly exposed to microbial products from the enteric microflora that are 
carried through the portal circulation, innate immune response to TLR ligands is 
normally regulated partly through the modulation of TLR signals, namely “liver 
tolerance” [49,56].  Therefore, a breakdown of this “liver tolerance” and/or 
excessive activation of TLR signaling may possibly be involved in the 
pathogenesis of various chronic inflammatory liver diseases such as 
alcohol-induced liver diseases, nonalcoholic steatohepatitis (NASH), hepatic 
fibrosis, ischemia/reperfusion liver injury, hepatocellular carcinoma (HCC) and 
hepatic autoimmune disorders including autoimmune hepatitis (AIH), primary 
biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC).  
 
Alcohol-induced liver injury 




Excessive alcohol intake injuries intestinal epithelial barrier causing 
increased intestinal permeability followed by elevated LPS levels in the portal 
circulation [51].  The LPS then activates TLR4 on Kupffer cells to produce 
proinflammatory cytokines, such as TNF-α, leading to hepatocyte damage. 
Chronic alcohol consumption upregulates hepatic TLR1, TLR2, TLR4, TLR6, 
TLR7, TLR8, TLR9, and CD14 mRNA expression and sensitizes to the 
corresponding TLR ligands to enhance TNF-α production [12].   
 
Non-alcoholic steatohepatitis (NASH) 
NASH is characterized by lipid accumulation in hepatocytes and 
inflammatory cell infiltration, which leads to hepatic fibrosis. In 
methionine/choline-deficient (MCD) diet–induced animal model of NASH, 
TLR4-signaling and Kupffer cells play pivotal roles in the pathogenesis of NASH 
[54]. The loss of TLR4 attenuates hepatic lipid accumulation and hepatic 
fibrogenic markers, such as collagen α1 and TGF-β1 in MCD diet-induced 
steatohepatitis, indicating the importance of TLR4 in NASH [57].   
 
Hepatic fibrosis 
Hepatic fibrosis results from chronic liver injury, which is caused by a 
variety of liver diseases including viral hepatitis, autoimmune hepatitis, 
cholestasis (PBC, PSC), alcohol-induced liver injury and NASH.  In these 
diseases, TLR4 signaling is considered to initiate fibrogenesis by inducing 
proinflammatory and profibrogenic cytokines of Kupffer cells, which then activate 
HSCs. Endogenous CpG-DNA from damaged hepatocytes activates HSCs to 
produce collagen via TLR9, while endogenous DNA also provide a stop signal for 
migrating activated HSCs as soon as they sense apoptotic DNA [65]. CD14, LBP, 
TLR4, and Myd88 are critical for hepatic fibrogenesis induced by bile duct ligation 
and CCl4 in mice [58]. The injection of TLR3 ligand poly-I:C inhibits HSCs 
activation mediated by IFN-γ from NK cells, which attenuating hepatic fibrosis. 
Chronic ethanol consumption abolishes this anti-fibrotic effect of TLR3, implying 
the mechanism by which alcohol induces liver fibrosis [57].  The genetic 
determinant for liver fibrosis is recently identified on TLR4 SNP [10].  
 
Autoimmune hepatitis (AIH) 
In mouse model of AIH induced by lymphocytic choriomeningitis virus 
infection, TLR3 but not TLR9 signaling plays a critical role in development of 
hepatocyte damage and inflammation via IFN-α/β, TNF-α and CXCL9 induction 
[33]. However, there has been no evidence for involvement of TLR signals in the 




development of human AIH. Multiple conditions can cause sensitization to 
endotoxin-induced liver injury including drugs, toxins, metabolic factors, and 
pathogens. This sensitization via upregulation of TLRs is mediated by 
bone-marrow derived immune cells but not by liver parenchymal cells [19]. 
 
Primary biliary cirrhosis (PBC) 
Monocytes from PBC patients appear to be more sensitive to the ligands for 
TLR2, TLR3, TLR4, TLR5, and TLR9, producing higher levels of proinflammatory 
cytokines, particularly IL-1β, IL-6, IL-8 and TNF-α [40].  In PBC patients B cells 
are characterized by high expression of TLR9, namely CpG, stimulating B cells to 
significant production of immunoglobulin M and anti-mitochondrial antibodies, 
indicating that occurring hyper responsiveness of B cells via TLR9 accelerate 
B-cell mediated autoimmunity in PBC [25,44]. The increased expression of TLR3 
and type 1 IFN mRNA is found in both the portal tract and parenchyma of 
PBC-diseased livers derived from early stage PBC patients, indicating the 
involvement of TLR3-type 1 IFN signaling pathway in the pathogenesis of PBC 
[62]. The marked increase of TLR3 proteins in small bile ducts of PBC-diseased 
liver indicate the involvement of TLR3 in pathogenesis of the bile duct damage in 
PBC, although the real endogenous or exogenous ligand for TLR3 is still unknown 
in PBC (Fig. 4) [47]. The expression of TLR4 is also increased in PBC-diseased 
livers [64]. These observations strongly indicate the involvement of TLR-signals 
in pathogenesis of PBC.  
 
Primary sclerosing cholangitis (PSC) 
Primary sclerosing cholangitis (PSC) is characterized by progressive 
inflammation and fibrosis of the medium to large sized hepatic bile ducts. High 
frequency of anti-BEC antibodies presence is found and the binding of anti-BEC 
antibodies to BECs induce production of proinflammatory cytokines and 
upregulation of TLRs. BECs expressing higher levels of TLR4 and TLR9 respond 
to their ligands interaction by production of higher levels of inflammatory 
cytokines, thus leading to destruction of BECs in PSC [7,24].  
 
In addition to the liver diseases mentioned above, TLR signaling is also 
considered to be involved in the pathogenesis of ischemia/reperfusion liver injury, 
liver regeneration and development of HCC.   
In conclusion, adequate strength of TLR signaling induces “beneficial” 
responses, such as microorganism clearance, regeneration, protection from cell 
death, and adjuvants for vaccination, whereas excessive TLR signaling triggers 




“harmful” responses, such as suppression of regenerative responses, chronic 
inflammation, necrosis, fibrosis, and induction of autoimmune liver diseases [50]. 
In order to identify the molecular target for the treatment of liver diseases, 
further studies are needed to clarify the role of innate immunity in the 
pathogenesis of these conditions.   
 
 
Liver cells in hepatic inflammation 
In the course of hepatic inflammation, where hepatocytes are the main 
target of immune-mediated destruction, non-parenchymal liver cells contribute to 
pro-inflammatory and/or immuno-modulatory functions. With distinct mode of 
actions, i.e. secretion of lymphocyte chemotactic factors, ability to support 
adhesion and to promote onward migration, antigen presentation, and T cell 
instruction, these cells exert substantial influence on inflammatory settings, as 
well as on basal normal state, where continual immuno-surveillance is in 
operation by professional immune cells. 
 
Hepatocytes  
  As hepatocytes are indeed the major cell type in the liver, they might 
represent primary modulators of hepatic immunity, especially in the setting of 
chronic liver injury, where non-injured hepatocytes in close proximity are 
predisposed to inflammatory mediators as bystanders. A line of evidence may 
support this idea. 67. Wiegaed et al [67] recently demonstrated that MHC-II 
expressing hepatocytes induced Th2-biased differentiation of uncommitted CD4+ 
T cells, and that suppressed the ability of previously differentiated Th1 to secrete 
IFN-γ in vitro. Accordingly in vivo, they found that MHC-II expression by 
hepatocytes was associated with impaired IFN- γ response and impaired 
lymphocytic choriomeningitis virus clearance [67]. MHC-II expressing 
hepatocytes in inflamed milieu may have strong influence on the chronicity of 
hepatitis, by instructing infiltrating CD4+T cells to differentiate into a less 
inflammatory phenotype [67]. Application of immuno-modulatory properties of 
hepatocytes is still challenging. Recent report clearly described that ectopic 
expression of neural autoantigen myelin basic protein (MBP) in the liver, either in 
liver-specific MBP transgenic mice or in transient gene transfer in vivo, induced 
protection from autoimmune necro-inflammation in a mouse model of multiple 
sclerosis, via generation of MBP-specific CD4+ CD25+ Foxp3+ Tregs [38].  
 




Sinusoidal endothelial cells  
Lymphocyte recruitment to the liver, especially within the hepatic 
sinusoids, is characterized by special features: in addition to the classical 
endothelial adhesion molecules, such as intercellular adhesion molecule-1 
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), other adhesion 
receptors appear to play more specific roles for lymphocyte recruitments to 
hepatic sinusoids [59]. These non-classical adhesion molecules in the LSEC 
include certain scavenging receptors, such as mannose receptor and common 
lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1), VAP-1, a 
170kDa homodimeric glycoprotein that has monoamine oxidase activity, and 
CD44. CXCL9-11 and CXCL16, chemokines, secreted not only by LSEC but also 
by inflamed cholangiocytes and hepatocytes, and subsequently presented on 
sinusoidal endothelia, are also required for recruitment/adhesion of lymphocytes 
and transmigration across LSEC [59]. 
  LSEC are specialized organ-resident APC, contributing to peripheral 
immune tolerance. With scavenger activity, they have been reported to have 
capacity to present exogenous antigens on both MHC-II and MHC-I molecules to 
CD4+ or CD8+T cells, respectively.  Diehl et al [6] recently demonstrated that 
cognate interaction with naïve CD8+T cells induced tolerogenic maturation of 
LSEC, characterized by the increased expression of co-inhibitory B7-H1: in 
contrast to dendritic cells (DC), tolerogenic maturation of LSEC was 
cell-autonomous, not controlled by exogenous mediators (such as transforming 
growth factor β, IL-10). Tolerization of CD8+T cells by matured LSEC is a unique, 
non-deletional process, dependent on B7-H1/programmed death 1 (PD-1) 
interaction.  
 
Hepatic stellate cells (HSC) and activated liver myofibroblasts (aLMF) 
HSC perform potent APC function for stimulation of CD4+/ CD8+T cells as 
well as NKT cells. Accordingly, mode of antigen presentation of HSC was 
demonstrated to be through either MHC-II/MHC-I, or CD1d, the latter of which 
presents lipid antigens. Additional work in mice clearly confirmed that antigen 
presentation by HSC promoted protection against Listeria monocytogenes 
infection in the liver. IFN-γ induced amplification of APC proteins, along with 
B7-H1 production, in turn adds immunomodulatory functions to HSC, giving rise 
to B7-H1 dependent T cell apoptosis in mice. HSC transdifferentiate into aLMF 
through the interaction with inflammatory cells, resulting in transformation into 
prominent fibrogenic cells in the liver [68]. Holt et al [18] recently observed that 
aLMF played a direct role in regulating the infiltration and positioning of 




lymphocytes through G-protein coupled receptor-dependent and -independent 
fashion in vitro, apparently relevant in chronic liver disease. In murine models of 
liver fibrosis, apoptosis of aLMF by macrophages is followed by spontaneous 
resolution of inflammation. Very recently, senescent aLMF in murine liver were 
demonstrated to exhibit gene expression profile consistent with reduced secretion 
of extracellular matrix components, enhanced secretion of extracellular 
matrix-degrading enzymes, and enhanced immune surveillance [29]. 
Consequently, senescent aLMF were poised for selective target of natural killer 
cells, resulting in fibrosis reversion with aLMF clearance. Finally, stellate 
cell-mediated T cell instruction was proposed by Winau et al [68]. HSC plays a 
pivotal role in vitamin A homeostasis, storing vitamin A and converting retinol 
into retinoic acid. Generation of induced regulatory T cells from naïve CD4+T cells 
in the periphery is dependent on retinoic acid as well as on TGF-β. Contrarily, 
retinoic acid inhibits the TGF-β/IL-6-inducing differentiation of inflammatory 
TH-17 cells [68]. Taken into account that HSC are capable of producing retinoic 
acid, TGF-β, and IL-6, it is plausible to have a scenario that HSC play a vital role 
in the instruction of regulatory T lymphocytes in the liver.  
 
Biliary epithelial cells 
Biliary epithelial cells that line the intrahepatic biliary tract are the 
primary site of innate immunity against microbials in bile. We reported that 
unstimulated conditioned medium of human cholangiocytes in vitro were already 
rich in multiple humoral factors, including ELR+CXC chemokines, such as 
IL-8/CXCL8, growth-related oncoprotein (GRO), epithelial neutrophil 
chemoattractant (ENA-78), known chemoattractants with wide range of 
non-leukocytic activities [27]. Moreover, human cholangiocytes were found to be 
permissive in TLR2, 4 and 3 dependent pathways in vitro, the former of which 
caused increase in the secretion of IL-6, monocyte chemotactic protein-1 (MCP-1), 
and IL-8, upon activation with LPS or LTA, respectively [72]. 
 
Biliary epithelial cells in immunological inflammation  
Several hepatobiliary diseases, especially PBC and PSC, appear to be 
mediated by a breakdown of self-tolerance, in which the immune reaction occurs 
against autoantigens expressed on biliary epithelial cells. PBC is one of 
organ-specific autoimmune diseases characterized by appearance of 
autoantibodies specific for epitopes of 2-oxo-acid dehydrogenase multi-enzyme 
complexes of mitochondria and histologically chronic non-suppurative destructive 




cholangitis (CNSDC). Liver-infiltrated mononuclear cells (LMNC) around small 
bile ducts are believed to destroy BECs. On the other hand, PSC may be mediated 
by an immune response against endothelial cells of the peribiliary capillary plexus, 
with secondary reactions to BEC antigens.  
 
Cell populations within and around BECs in PBC 
Cytokines produced by lymphocytes infiltrating around CNSDC are 
closely associated with the progression of bile duct injury in PBC because BECs 
bear several cytokine receptors against interleukin (IL)-4, IL-6, interferon (IFN)-γ, 
and tumor necrosis factor (TNF)- [13]. In addition, BECs themselves also 
produce TNF-α and IL-6. It has been demonstrated that T cells are predominant 
cell type of the inflammatory cells within the portal tracts in PBC [28,70]. 
Moreover, in the development of cholangiopathy, the infiltration of immune cells 
within the biliary epithelial layer and the direct adhesion between BEC and 
immune cells are key events leading to cell-mediated cytotoxicity and apoptosis of 
BECs [15,71]. A number of proinflammatory cytokines are known to be elevated in 
the local portal tract microenvironment in PBC, contributing to development of 
chronic inflammatory reaction around the bile ducts, and BECs as well as 
immune cells actively participate in this inflammatory process. Immunoreactivity 
and autoimmunity are regulated at least by three different types of CD4+helper T 
cells; Th1, Th2 and Th17 subsets, principally subdivided by distinctive cytokine 
production and effector functions. Th1 cells which secrete IL-2, IFN-γ, involved in 
the cell-mediated response provide help to cytotoxic CD8+T lymphocytes, activate 
natural killer cells, and produce delayed hypersensitivity reactions. In contrast, 
Th2 clones secrete IL-4 and IL-10, while Th17 cells which produce IL-17 are now 
considered as commanders for autoimmunity [3]. Presence of predominant Th1 
cytokine profile is demonstrated in PBC [2]. Cytokine profiles determined 
primarily from stimulated peripheral blood and liver-derived T lymphocytes may 
be misleading for defining a Th1/Th2 cytokine profile in PBC [37,41]. In situ 
hybridization study reveals that IFN- γ mRNA-expressing mononuclear cells are 
more commonly detected primarily around damaged bile ducts in PBC livers than 
IL-4 mRNA-expressing cells and that the level of IFN- γ mRNA expression is 
highly correlated with the degree of portal inflammatory activity [16].. A recent 
study has reported that CD8+ and CD4+ (in particular CD4+ CD28−) T cells are 
markedly increased as intraepithelial lymphocytes within damaged bile ducts in 
PBC [20]. Since these unique CD4+CD28− T cells proliferate in target tissues of 
autoimmune diseases and are associated with Th1/Th2 balance in the regulation 
of spontaneous autoimmune diseases by possessing high expression of IFN-γ and 




auto-reactive and cytolytic function, CD4+CD28−T cells may be involved in the 
pathogenesis of auto-immune-mediated bile duct damage of PBC [22].  
Additionally with these three CD4+T cells (Th1, Th2 and Th17), 
regulatory T cells must be mentioned. Regulatory T cells have two types; natural 
occurring CD4+CD25+Foxp3+T cells and acquired IL-10-producing Th3 cells. 
Autoimmunity will occur when regulatory T cells decrease functionally or 
numerically. Recently it is reported that natural occurring regulatory T cells are 
decreased around CNSDC in PBC [32]. 
 
Chemokine and bile ducts 
Leukocyte migration depends on existence of a chemoattractant gradient 
created by a large family of molecules known as chemokines. Because of their role 
in inflammation, chemokines and their receptors are known to play a crucial part 
in directing the movement of mononuclear cells throughout the body, engendering 
the adaptive immune response and contributing to the pathogenesis of a variety of 
diseases [4]. The migration and accumulation of leukocytes in the target organs 
are a critical step in the pathogenesis of autoimmune diseases [43,45].  
Chemokines provide a sustained inflammatory bridge between innate and 
acquired immunity [31]. BECs are one of the sources of chemokines, and BECs 
spontaneously produce GRO-α/CXCL1, ENA-78/CXCL5, GCP-2/CXCL6, 
IL-8/CXCL8 (Figure 5) [27,60]. Fractalkine (CX3CL1), consisting of a 
membrane-bound form and a soluble chemotactic form, is produced by several 
epithelial cells and is associated with cell adhesion and the chemoattractant for 
its receptor (CX3CR1)-expressing cells such as CD8+ and CD4+T cells. In PBC, 
the expression of CX3CL1 is upregulated in injured bile ducts of PBC, and the 
CD4+ and CD8+ lymphocytes expressing CX3CR1 are found in portal tracts and 
within the biliary epithelial layer of injured bile ducts.  
Defense against invading pathogens by cells of the innate immune system 
involves the rapid recognition of conserved PAMPs through members of TLR 
protein family [30,35]. BECs locate in the pathway from the gut to the liver and 
constitutively express transcripts encoding several TLRs [5,72]. Moreover, the 
expression levels of TLR-3 and -4 are high in the portal tract in PBC [62,64] and 
stimulation with TLR3, BECs induce MIP-1α/CCL3, MIP-1α/CCL4, 
RANTES/CCL5, and IP-10/CXCL10. 
It is reported that damaged BECs in PBC and, to a lesser degree and 
frequency, in other hepatobiliary diseases, expressed HLA-DR antigens [48], and 
that the bile ducts in PBC liver tissues frequently expressed increased levels of 
CD40 associated with apoptotic BECs [1]. There were also some studies dealing 




with the differences of surface markers of BEC from PBC patients by 
immunohistochemical studies [63]. It was previously found that IFN-γ stimulates 
BECs to express HLA DR [23], and it is now shown that TLR3 ligands stimulate 
BECs to express HLA DR and CD40, indicating that the cultured circumstance of 
special condition makes BECs to change to the PBC phenotype. It is now 
suggested that PBC does not occur as a result by changed BECs, but BECs would 
change as a result of the developing PBC [60].    
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AIH : autoimmune hepatitis  
aLMF : activated liver myofibroblasts  
APC : antigen-presenting cell  
BEC : biliary epithelial cells  
cDC : conventional DC 
CLEVER-1: common lymphatic endothelial and vascular endothelial receptor-1 
CNSDC : chronic non-suppurative destructive cholangitis  
DAMPs : damage associated molecular pattern  
DC : dendritic cells  
ENA-78: epithelial neutrophil chemoattractant  
GRO : growth-related oncoprotein  
HSCs : Hepatic stellate cells  
ICAM-1: intercellular adhesion molecule-1  
IFN : interferon  
IL : interleukin  
HCC : hepatocellular carcinoma 
JNK : jun N-terminal kinase  
LPS : lipopolysaccharide  
LMNC : liver infiltrated mononuclear cells  
LSEC : liver sinusoidal endothelial cells  
MBP : myelin basic protein  
MCD : methionine/choline-deficient  
MCP-1: monocyte chemotactic protein-1  
NASH : non-alcoholic steatohepatitis  
NOD : nucleotide-binding oligomerization domain  
PAMPs : pathogen-associated molecular patterns  
PBC : primary biliary cirrhosis  
pDC : plasmatoid DC 
PRRs : pattern-recognition receptors  
PSC : primary sclerosing cholangitis  
ROS : reactive oxygen species 
TLR : toll-like receptor  
TNF : tumor necrosis factor 
VCAM-1: vascular cell adhesion molecule-1  
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Fig. 4 Expression of TLR3 on intrahepatic biliary epithelial cells in normal and 
PBC livers. 
TLR3 is strongly expressed on intrahepatic biliary epithelial cells in vivo, 
especially at sites of ductular reactions, in livers from patients with PBC (B), 




Fig. 5 Cytokines and chemokines produced by cultured BEC. BECs were studied 
under basal conditions for 48 hours; thence cell-free culture supernatants were 
analyzed by a protein array kit to evaluate 174 different proteins simultaneously. 
Unstimulated cells produced detectable amounts of GRO-α/CXCL1, 
ENA-78/CXCL5, GCP-2/CXCL6 and IL-8/CXCL8 (ref. 27, 60). 
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